Staphylococcus aureus bacteremia: A critical review of its treatment and association with infective endocarditis.
D000328:Adult; D000368:Aged; D001769:Blood / Q000382:microbiology; D002511:Cephalosporins / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D002648:Child; D003023:Cloxacillin / Q000627:therapeutic use; D004697:Endocarditis, Bacterial / Q000175:diagnosis / Q000209:etiology* / Q000601:surgery; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use; D006326:Heart Auscultation; D006760:Hospitalization; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use; D008297:Male; D008712:Methicillin / Q000627:therapeutic use; D008875:Middle Aged; D010403:Penicillin Resistance; D010406:Penicillins / Q000627:therapeutic use; D019736:Prostheses and Implants / Q000009:adverse effects; D012008:Recurrence; D018805:Sepsis / Q000150:complications / Q000209:etiology* / Q000628:therapy; D013203:Staphylococcal Infections / Q000150:complications / Q000601:surgery / Q000628:therapy; D013997:Time Factors
D002511:Cephalosporins; D005839:Gentamicins; D010406:Penicillins; D007612:Kanamycin; D003023:Cloxacillin; D008712:Methicillin; D002512:Cephalothin